Autoimmune Disease Diagnostics Market Size to reach USD 8.80 Billion in 2032- Emergen Research

Increasing prevalence of autoimmune disorders is a key factor driving the market revenue growth. The global autoimmune disease diagnostics market size was USD 5.37 Billion in 2022 and is expected to register a revenue CAGR of 5.0% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of autoimmune disorders is a key factor driving the market revenue growth.
Integrated autoimmune disease diagnosis is the process of using different diagnostic tools to find autoimmune diseases that affect different organs and body systems. Autoimmune diseases like rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus are becoming more common, which is driving the need for integrated diagnostics for autoimmune illnesses. The National Institutes of Health says that more than 23 million Americans have autoimmune diseases, and they expect that number to grow in the coming years. This has led to a rise in study and development in the field of diagnosing autoimmune diseases, which has helped the integrated autoimmune disease diagnostics market grow.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/1855

The growing number of autoimmune diseases around the world is one of the main things driving the integrated autoimmune disease testing market. The World Health Organisation says that autoimmune illnesses are one of the top ten reasons why women under 65 die. The number of people getting these diseases is going up because of things like genetics, the environment, and changes in living. The need for integrated autoimmune disease diagnostics is being driven by the fact that both patients and doctors are becoming more aware of how important early detection and treatment of autoimmune diseases are.

The growing use of advanced diagnostic methods like immunoassays, flow cytometry, and polymerase chain reaction (PCR) is another thing that is making the market for integrated autoimmune disease diagnostics rise. These methods are both sensitive and specific, which makes it easier to diagnose autoimmune diseases correctly. The growth of the integrated autoimmune disease diagnostics market is also helped by the creation of new biomarkers and tests for autoimmune diseases.

Major Companies and Competitive Landscape:

The autoimmune disease diagnostics market is highly competitive and rapidly evolving, with numerous players operating in the industry. Established players such as Abbott Laboratories, Biomérieux, Trinity Biotech plc, Siemens Healthineers GmbH, F. Hoffmann-La Roche Ltd, Euroimmun Medizinische Labordiagnostika AG, Quest Diagnostics, Beckman Coulter Inc., Bio-Rad Laboratories Inc., and Thermo Fisher Scientific.

These companies invest heavily in research and development to introduce innovative products, engage in partnerships and collaborations to expand their product portfolios and geographical presence. In addition to established players, emerging players such as SQI Diagnostics, ImmunArray Ltd., and Myriad Genetics Inc. are leveraging advanced technologies such as artificial intelligence and machine learning to develop new diagnostic tools for autoimmune diseases. Regional players with a strong distribution network and known for providing customized solutions to their customers also exist. Overall, with new players entering the market and existing players introducing innovative products, the autoimmune disease diagnostics market is expected to witness intense competition in the coming years.

The growing prevalence of autoimmune diseases and increasing awareness among patients and healthcare providers about the importance of early diagnosis and treatment are driving the growth of the autoimmune disease diagnostics market. The market is also witnessing an increasing trend towards point-of-care (POC) testing, which is driving the demand for rapid and accurate diagnostic tests.

To gain a competitive edge in the market, players are focusing on product differentiation, geographic expansion, and mergers and acquisitions. For instance, in February 2021, Abbott Laboratories acquired the medical device company Walk Vascular, LLC, to expand its product portfolio in the peripheral vascular market. Similarly, in 2020, DiaSorin S.p.A. acquired Luminex Corporation, a leader in multiplexing technology and molecular diagnostics, to expand its presence in the US market.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1855

Segmentation Insights for Autoimmune Disease Diagnostics Market Report:

The global autoimmune disease diagnostics market has been segmented by Emergen Research on the basis of disease type, test type, end-use, and region. Based on disease type, the market is segmented into systemic autoimmune disease, including rheumatoid arthritis, psoriasis, systemic lupus erythematosus (SLE), multiple sclerosis, and others, and localized autoimmune disease, including inflammatory bowel disease, type 1 diabetes, thyroid, idiopathic thrombocytopenic purpura, and others.

On the basis of test type, the autoimmune disease diagnostics market is segmented into antinuclear antibody tests, autoantibody tests, complete blood count (CBC), C-reactive protein (CRP), urinalysis, rheumatoid factor test, and others. Based on end-use, the market is segmented into hospitals, diagnostic centers, and academic & research institutes.

Geographically, the autoimmune disease diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America region includes the U.S., Canada, and Mexico. The European region includes Germany, France, the U.K., Italy, Spain, Benelux, and the rest of Europe. The Asia Pacific region includes China, India, Japan, South Korea, and the rest of APAC. The Latin America region includes Brazil and the rest of LATAM. The Middle East & Africa region includes Saudi Arabia, UAE, South Africa, Turkey, and the rest of MEA.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/autoimmune-disease-diagnostics-market

Eric Lee
Corporate Sales Specialist
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions.

This release was published on openPR.